Remove 2027 Remove Biosimilars Remove Packaging
article thumbnail

Injectable Drug Delivery 2022

pharmaphorum

reaching £915 billion by 2027. Delve into the world of biologics and biosimilars and what these mean for the injectable drug market. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% Develop your understanding of high-volume and long-acting injectable compounds. Device Engineering.

article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. the enteric coating and the capsule dissolve.